Literature DB >> 34146068

Cilioretinal artery occlusion with paracentral acute middle maculopathy associated with COVID-19.

Cemal Ozsaygılı1, Nurettin Bayram1, Hakan Ozdemir2.   

Abstract

The purpose of the study is to describe cilioretinal artery (CILRA) occlusion that is presumed to be associated with COVID-19 without severe respiratory distress and inform ophthalmologists of unusual ocular presentations of COVID-19. Here, we present the first case of a patient with isolated CILRA occlusion and paracentral acute middle maculopathy (PAMM) after recently polymerase chain reaction-proven COVID-19. A 26-year-old female patient presented with a visual field defect in her left eye for 2 days and decreased vision compared to her right eye. It was learned that the patient had a laboratory-proven COVID-19 infection with mild respiratory symptoms that did not require hospitalization 2 weeks ago. Fundus examination revealed retinal edema in the left eye area supplied by the CILRA. Spectral-domain optical coherence tomography revealed a prominent hyperreflective band at the inner nuclear layer level. These findings led us to the diagnosis of isolated CILRA occlusion and PAMM associated with recent COVID-19. CILRA occlusion and PAMM could be associated with the inflammatory and procoagulant condition caused by the SARS-CoV-2 infection.

Entities:  

Keywords:  COVID-19; Cilioretinal artery occlusion; SARS-CoV-2; ophthalmology; paracentral acute middle maculopathy retina

Year:  2021        PMID: 34146068     DOI: 10.4103/ijo.IJO_563_21

Source DB:  PubMed          Journal:  Indian J Ophthalmol        ISSN: 0301-4738            Impact factor:   1.848


  3 in total

1.  Paracentral acute middle maculopathy and COVID-19 vaccination: Causation versus coincidence finding.

Authors:  Alireza Dehghani; Heshmatollah Ghanbari; Mohammad-Hossein Houshang-Jahromi; Mohsen Pourazizi
Journal:  Clin Case Rep       Date:  2022-03-13

2.  Branch Retinal Artery Occlusions, Paracentral Acute Middle Maculopathy and Acute Macular Neuroretinopathy After COVID-19 Vaccinations.

Authors:  Koki Ishibashi; Hiroyuki Yatsuka; Masatoshi Haruta; Kenichi Kimoto; Shigeo Yoshida; Toshiaki Kubota
Journal:  Clin Ophthalmol       Date:  2022-03-31

3.  Analysis of COVID-19 publications in the Indian Journal of Ophthalmology during two years of the pandemic and their impact on ophthalmic literature.

Authors:  Bharat Gurnani; Kirandeep Kaur
Journal:  Indian J Ophthalmol       Date:  2022-05       Impact factor: 2.969

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.